AzTrials
AzTrials

Low Back PainPhase 1/2NCT01168999

The Mechanisms of Manual Therapy in the Treatment of Low Back Pain

A Phase 1/2 study testing spinal manipulation in people with Low Back Pain, run by University of Florida at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether a novel placebo for comparison to spinal manipulation is believable and creates similar expectation for treatment effectiveness as the studied spinal manipulation technique. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Low Back Pain
What is being tested?
spinal manipulation
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
110 participants
Where
1 siteUnited States
Study dates
Sep 2009to Jan 2013
Phase
Phase 1/2
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • currently experiencing low back pain which does not extend below the knees
  • rate the low back pain as a minimum of 4/10 at worst over the past 24 hours
  • appropriate for conservative management of low back pain
  • english speaking

Who cannot join

  • surgery to the low back over the past 6 months
  • systemic disease known to effect sensation
  • other chronic pain condition unrelated to low back pain
  • fracture as a cause of low back pain

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Florida

    Gainesville, Florida, 32610

Other trials in United States

About this study

The purpose of this study is to determine whether a novel placebo for comparison to spinal manipulation is believable and creates similar expectation for treatment effectiveness as the studied spinal manipulation technique. Additionally, we wish to compare outcomes related to low back pain, function, and pain sensitivity between people receiving the placebo, spinal manipulation, and no therapy.

Conditions
Low Back Pain
Being tested
spinal manipulation, sham spinal manipulation, Enhanced sham spinal manipulation
Keywords
low back pain, spinal manipulation, manual therapy, placebo
Medical subject headings
Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • spinal manipulationOther

    Spinal manipulation commonly used in the treatment of low back pain and known to be effective for some individuals experiencing low back pain

  • sham spinal manipulationOther

    Sham spinal manipulation intended to mimic the studied spinal manipulation

  • Enhanced sham spinal manipulationOther

    Sham spinal manipulation intended to mimic the studied spinal manipulation and provided with the instructions, "The manual therapy technique you will receive has been shown to significantly reduce low back pain in some people"

Study groups in NCT01168999
Study groupRoleWhat they receive
spinal manipulationActive comparatora spinal manipulation known to be effective in the treatment of low back pain for some individuals
Receives: Other: spinal manipulation
sham spinal manipulationPlacebo comparatora sham spinal manipulation intended to mimic the studied spinal manipulation
Receives: Other: sham spinal manipulation
natural historyNo interventionNo intervention is provided to participants in this arm of the study
Enhanced sham spinal manipulationPlacebo comparatora sham spinal manipulation intended to mimic the studied spinal manipulation and provided with the instructions, "The manual therapy technique you will receive has been shown to significantly reduce low back pain in some people"
Receives: Other: Enhanced sham spinal manipulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Believability of Placebo

    Assess whether or not participants receiving the placebo are blinded to the fact they are receiving the placebo as indicated by the percentage of participants in each arm of the study believing they received SMT

    Measured: baseline

  2. Expectation for Treatment Effectiveness

    how helpful participants expect the assigned intervention will be in decreasing their low back pain

    Measured: baseline

  3. Change From Baseline at 2 Weeks in Clinical Pain as Measured by a Numeric Rating Scale

    A 101 point numeric rating scale with 0= no pain at all to 100= worst pain imaginable of low back pain

    Measured: Change from Baseline at 2 weeks

  4. Change From Baseline at 2 Weeks in Disability as Measured by the Oswestry Disability Index

    The Oswestry Disability Index is a 10 item questionnaire measuring low back pain related disability. Individual item scores range from 0 to 5. Scores on all items are summed and multiplied by 2 to provide a percentage ranging between 0 to 100 with higher scores indicating greater low back pain related disability.

    Measured: Change from Baseline at 2 weeks

  5. Change in Pain Sensitivity From Baseline to Immediately Following the Assigned Intervention as Measured by a Visual Analog Scale

    Participants received a standard thermal stimulus to the bottom of their foot prior to and immediately following their assigned intervention. Participants rated their pain in response to this thermal stimulus using a 101 mm visual analog scale with 0 mm indicating "no pain at all" and 100 mm indicating "the worst pain imaginable".

    Measured: baseline and immediately following their assigned intervention during the initial session

Secondary outcomes (4)
  1. Change From Baseline at 2 Weeks in Low Back Flexion Range of Motion

    Low back flexion range of motion was measured in degrees using a gravity inclinometer

    Measured: Change from Baseline at 2 weeks

  2. Change From Baseline at 2 Weeks in Low Back Extension Range of Motion

    Low back extension range of motion was measured in degrees using a gravity inclinometer

    Measured: Change from Baseline at 2 weeks

  3. Change From Baseline at 2 Weeks in Low Back Right Sidebending Range of Motion

    Low back right sidebending range of motion was measured in degrees using a gravity inclinometer

    Measured: Change from Baseline at 2 weeks

  4. Change From Baseline at 2 Weeks in Low Back Left Sidebending Range of Motion

    Low back left sidebending range of motion was measured in degrees using a gravity inclinometer

    Measured: Change from Baseline at 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jul 2010 (estimated)
  2. Study startSep 2009
  3. Primary completionJan 2013
  4. Study completionJan 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
110 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01168999
Sponsor's protocol ID
345-2009
Status last verified
Oct 2015
First submitted
22 Jul 2010
Last updated
28 Oct 2015
Data monitoring committee
No

Publications

  • Bialosky JE, George SZ, Horn ME, Price DD, Staud R, Robinson ME. Spinal manipulative therapy-specific changes in pain sensitivity in individuals with low back pain (NCT01168999). J Pain. 2014 Feb;15(2):136-48. doi: 10.1016/j.jpain.2013.10.005. Epub 2013 Oct 27.

    PubMed 24361109

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing spinal manipulation in people with Low Back Pain, run by University of Florida at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Oct 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Yes. Results are posted in the registry (first posted 23 Dec 2013). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Believability of Placebo (time frame: baseline). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01168999, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in